Inflammatory Markers, Metabolic Profile, and Psychoneurological Symptoms in Women with Breast Cancer: A Literature Review
- PMID: 34976536
- PMCID: PMC8713038
- DOI: 10.7759/cureus.19953
Inflammatory Markers, Metabolic Profile, and Psychoneurological Symptoms in Women with Breast Cancer: A Literature Review
Abstract
Breast cancer is one of the most prevalent cancers in women. The improvement in breast cancer treatment has significantly increased the proportion of survival rate for women with breast cancer. Despite the advancement in breast cancer treatment, a great proportion of survivors suffer from co-occurring psychoneurological symptoms which impact their quality of life. The most frequently reported psychoneurological symptoms among women with breast cancer are depressive symptoms, anxiety, fatigue, sleep disturbances, and pain. These symptoms usually appear as a cluster. Inflammatory activation and serum metabolic alterations have been associated with the etiology of cancer and with various chronic neurocognitive disorders. However, to date, no studies considered the combined effects of inflammatory markers and metabolites in the development of psychoneurological symptoms in women with breast cancer especially those who were treated with chemotherapy. Further clarification of the relationships between the inflammatory markers, serum metabolic alterations, and psychoneurological symptoms in women with breast cancer should be pursued.
Keywords: breast cancer; inflammatory markers; metabolic profile; metabolites; psychoneurological symptoms.
Copyright © 2021, Al-Bashaireh et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- American Cancer Society: cancer facts and figures. [ Jul; 2021 ];https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-... 2020
-
- Symptom clusters in breast cancer across 3 phases of the disease. Bender CM, Ergÿn FS, Rosenzweig MQ, Cohen SM, Sereika SM. Cancer Nurs. 2005;28:219–225. - PubMed
-
- Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PL. Support Care Cancer. 2002;10:329–336. - PubMed
-
- Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Byar KL, Berger AM, Bakken SL, Cetak MA. Oncol Nurs Forum. 2006;33:0. - PubMed
-
- The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study. So WK, Marsh G, Ling WM, Leung FY, Lo JC, Yeung M, Li GK. Oncol Nurs Forum. 2009;36:0. - PubMed
Publication types
LinkOut - more resources
Full Text Sources